Cargando…
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
BACKGROUND: Biopsy is the usual gold standard for liver steatosis assessment. The aim of this study was to identify a panel of biomarkers (SteatoTest), with sufficient predictive values, for the non-invasive diagnosis of steatosis in patients with or without chronic liver disease. Biomarkers and pan...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1327680/ https://www.ncbi.nlm.nih.gov/pubmed/16375767 http://dx.doi.org/10.1186/1476-5926-4-10 |
_version_ | 1782126514557419520 |
---|---|
author | Poynard, Thierry Ratziu, Vlad Naveau, Sylvie Thabut, Dominique Charlotte, Frederic Messous, Djamila Capron, Dominique Abella, Annie Massard, Julien Ngo, Yen Munteanu, Mona Mercadier, Anne Manns, Michael Albrecht, Janice |
author_facet | Poynard, Thierry Ratziu, Vlad Naveau, Sylvie Thabut, Dominique Charlotte, Frederic Messous, Djamila Capron, Dominique Abella, Annie Massard, Julien Ngo, Yen Munteanu, Mona Mercadier, Anne Manns, Michael Albrecht, Janice |
author_sort | Poynard, Thierry |
collection | PubMed |
description | BACKGROUND: Biopsy is the usual gold standard for liver steatosis assessment. The aim of this study was to identify a panel of biomarkers (SteatoTest), with sufficient predictive values, for the non-invasive diagnosis of steatosis in patients with or without chronic liver disease. Biomarkers and panels were assessed in a training group of consecutive patients with chronic hepatitis C and B, alcoholic liver disease, and non-alcoholic fatty liver disease, and were validated in two independent groups including a prospective one. Steatosis was blindly assessed by using a previously validated scoring system. RESULTS: 310 patients were included in the training group; 434 in three validation groups; and 140 in a control group. SteatoTest was constructed using a combination of the 6 components of FibroTest-ActiTest plus body mass index, serum cholesterol, triglycerides, and glucose adjusted for age and gender. SteatoTest area under the ROC curves was 0.79 (SE = 0.03) in the training group; 0.80 (0.04) in validation group 1; 0.86 (0.03) in validation group 2; and 0.72 (0.05) in the validation group 3 – all significantly higher than the standard markers: γ-glutamyl-transpeptidase or alanine aminotransferase. The median SteatoTest value was 0.13 in fasting controls; 0.16 in non-fasting controls; 0.31 in patients without steatosis; 0.39 in grade 1 steatosis (0–5%); 0.58 in grade 2 (6–32%); and 0.74 in grade 3–4 (33–100%). For the diagnosis of grade 2–4 steatosis, the sensitivity of SteatoTest at the 0.30 cut-off was 0.91, 0.98, 1.00 and 0.85 and the specificity at the 0.70 cut-off was 0.89, 0.83, 0.92, 1.00, for the training and three validation groups, respectively. CONCLUSION: SteatoTest is a simple and non-invasive quantitative estimate of liver steatosis and may reduce the need for liver biopsy, particularly in patients with metabolic risk factor. |
format | Text |
id | pubmed-1327680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-13276802006-01-14 The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis Poynard, Thierry Ratziu, Vlad Naveau, Sylvie Thabut, Dominique Charlotte, Frederic Messous, Djamila Capron, Dominique Abella, Annie Massard, Julien Ngo, Yen Munteanu, Mona Mercadier, Anne Manns, Michael Albrecht, Janice Comp Hepatol Research BACKGROUND: Biopsy is the usual gold standard for liver steatosis assessment. The aim of this study was to identify a panel of biomarkers (SteatoTest), with sufficient predictive values, for the non-invasive diagnosis of steatosis in patients with or without chronic liver disease. Biomarkers and panels were assessed in a training group of consecutive patients with chronic hepatitis C and B, alcoholic liver disease, and non-alcoholic fatty liver disease, and were validated in two independent groups including a prospective one. Steatosis was blindly assessed by using a previously validated scoring system. RESULTS: 310 patients were included in the training group; 434 in three validation groups; and 140 in a control group. SteatoTest was constructed using a combination of the 6 components of FibroTest-ActiTest plus body mass index, serum cholesterol, triglycerides, and glucose adjusted for age and gender. SteatoTest area under the ROC curves was 0.79 (SE = 0.03) in the training group; 0.80 (0.04) in validation group 1; 0.86 (0.03) in validation group 2; and 0.72 (0.05) in the validation group 3 – all significantly higher than the standard markers: γ-glutamyl-transpeptidase or alanine aminotransferase. The median SteatoTest value was 0.13 in fasting controls; 0.16 in non-fasting controls; 0.31 in patients without steatosis; 0.39 in grade 1 steatosis (0–5%); 0.58 in grade 2 (6–32%); and 0.74 in grade 3–4 (33–100%). For the diagnosis of grade 2–4 steatosis, the sensitivity of SteatoTest at the 0.30 cut-off was 0.91, 0.98, 1.00 and 0.85 and the specificity at the 0.70 cut-off was 0.89, 0.83, 0.92, 1.00, for the training and three validation groups, respectively. CONCLUSION: SteatoTest is a simple and non-invasive quantitative estimate of liver steatosis and may reduce the need for liver biopsy, particularly in patients with metabolic risk factor. BioMed Central 2005-12-23 /pmc/articles/PMC1327680/ /pubmed/16375767 http://dx.doi.org/10.1186/1476-5926-4-10 Text en Copyright © 2005 Poynard et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Poynard, Thierry Ratziu, Vlad Naveau, Sylvie Thabut, Dominique Charlotte, Frederic Messous, Djamila Capron, Dominique Abella, Annie Massard, Julien Ngo, Yen Munteanu, Mona Mercadier, Anne Manns, Michael Albrecht, Janice The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis |
title | The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis |
title_full | The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis |
title_fullStr | The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis |
title_full_unstemmed | The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis |
title_short | The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis |
title_sort | diagnostic value of biomarkers (steatotest) for the prediction of liver steatosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1327680/ https://www.ncbi.nlm.nih.gov/pubmed/16375767 http://dx.doi.org/10.1186/1476-5926-4-10 |
work_keys_str_mv | AT poynardthierry thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT ratziuvlad thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT naveausylvie thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT thabutdominique thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT charlottefrederic thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT messousdjamila thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT caprondominique thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT abellaannie thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT massardjulien thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT ngoyen thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT munteanumona thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT mercadieranne thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT mannsmichael thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT albrechtjanice thediagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT poynardthierry diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT ratziuvlad diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT naveausylvie diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT thabutdominique diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT charlottefrederic diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT messousdjamila diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT caprondominique diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT abellaannie diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT massardjulien diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT ngoyen diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT munteanumona diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT mercadieranne diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT mannsmichael diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis AT albrechtjanice diagnosticvalueofbiomarkerssteatotestforthepredictionofliversteatosis |